Erste „Advanced Heart Failure Unit“ am Herzzentrum der Universitätsklinik Heidelberg

Schlüsselwörter

terminale Herzinsuffizienz - Herzinsuffizienz-Wachstation

Keywords

terminal heart failure - advanced heart failure unit

• Literatur

• 1 Abraham WT, Adams KF, Fonarow GC et al. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications. J Am Coll Cardiol 2005; 46: 57-64
• 2 Bart BA, Goldsmith SR, Lee KL et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med 2012; 67: 2296-2304
• 3 Blomkalns AL, Gibler WB. Development of the chest pain center: rationale, implementation, efficacy, and cost-effectiveness. Prog Cardiovasc Dis 2004; 46: 393-403
• 4 Breuckmann F, Post F, Giannitsis E et al. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung für „Chest-Pain-Units“. Kardiologe 2008; 2: 389-394
• 5 Burger AJ, Elkayam U, Neibaur MT et al. Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy. Am J Cardiol 2001; 88: 35-39
• 6 Costanzo MR, Guglin ME, Saltzberg MT et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007; 49: 675-683
• 7 Costanzo MR, Saltzberg MT, Jessup M et al. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD. J Card Fail 2010; 16: 277-284
• 8 De Vroey F, Plein D, Vercauteren S et al. Rescue extracorporeal circulation as bridge to recovery in fulminant cocaine-induced heart failure. Int J Cardiol 2009; 133: e111-113
• 9 de Waha S, Desch S, Eitel I et al. What is the evidence for IABP in STEMI with and without cardiogenic shock?. Ther Adv Cardiovasc Dis 2012; 6: 123-132
• 10 Post F, Giannitsis E, Riemer T et al. Pre- and early in-hospital procedures in patients with acute coronary syndromes: first results of the „German chest pain unit registry“. Clin Res Cardiol 2012; 101: 983-991
• 11 Gage J, Rutman H, Lucido D et al. Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure. Circulation 1986; 74: 367-373
• 12 Hasin Y, Danchin N, Filippatos GS et al. Recommendations for the structure, organization, and operation of intensive cardiac care units. Eur Heart J 2005; 26: 1676-1682
• 13 Hertz MI, Aurora P, Christie JD et al. Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J Heart Lung Transplant 2008; 27: 937-942
• 14 Julian DG. The evolution of the coronary care unit. Cardiovasc Res 2001; 51: 621-624
• 15 Kirklin JK, Naftel DC, Kormos RL et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012; 31: 117-126
• 16 Kokkinos PF, Choucair W, Graves P et al. Chronic heart failure and exercise. Am Heart J 2000; 140: 21-28
• 17 Mager G, Klocke RK, Kux A et al. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure. Am Heart J 1991; 121: 1974-1983
• 18 McMurray JJ, Adamopoulos S, Anker SD et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012; 33: 1787-1847
• 19 Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-1172
• 20 Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443
• 21 Seyfarth M, Sibbing D, Bauer I et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008; 52: 1584-1588
• 22 Sheu JJ, Tsai TH, Lee FY et al. Early extracorporeal membrane oxygenator-assisted primary percutaneous coronary intervention improved 30-day clinical outcomes in patients with ST-segment elevation myocardial infarction complicated with profound cardiogenic shock. Crit Care Med 2010; 38: 1810-1817
• 23 Slaughter MS, Rogers JG, Milano CA et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009; 361: 2241-2251
• 24 Slawsky MT, Colucci WS, Gottlieb SS et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation 2000; 102: 2222-2227
• 25 Statistisches-Bundesamt. Die 20 häufigsten Hauptdiagnosen der vollstationär behandelten Patienten (einschl. Sterbe- und Stundenfälle) nach der International Statistical Classification of Diseases and Related Health Problems (ICD-10) 2010. www.destatis.de 2012;
• 26 Thiele H, Zeymer U, Neumann FJ et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296